BRAF and neoplasm: PTEN is regulated as a tumor suppressor with complete PTEN loss (usually accompanied by genomic deletion) seen in 20-25% of melanomas (including those with BRAF mutation) [38-42], and is highly associated with uniform high-level AKT activation [43].